Remote Executive Director, Corporate Development

A biotechnology company based in Waltham, MA, is seeking an Executive Director of Corporate Development to lead strategic initiatives and partnerships. The ideal candidate will have over 12 years of experience in the biotech/pharma industry, excellent communication skills, and a proven track record of executing strategic transactions. This position offers a...

Executive Director, Corporate Development Join to apply for the Executive Director, Corporate Development role at Dyne Therapeutics Company Overview Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous...

Executive Director, Bioanalytical Development Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for myotonic...

Executive Director, Bioanalytical Development Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for myotonic...

Job TitleDirector - Corporate FP&ALocation(s)WalthamRevvity is a developer and provider of end-to-end solutions designed to help scientists, researchers, and clinicians solve the world's greatest health challenges. We pair the enthusiasm of an industry disruptor with the experience of a longtime leader. Our team of 11,000+ colleagues from around the globe...

About Us Crescent Biopharma’s vision is to build a world leading oncology company bringing the next wave of therapies for cancer patients. The Company’s clinical‑stage pipeline includes its lead program, a PD‑1 x VEGF bispecific antibody, as well as novel antibody‑drug conjugates. By leveraging multiple modalities and established targets, Crescent...

About Us Crescent Biopharma’s vision is to build a world leading oncology company bringing the next wave of therapies for cancer patients. The Company’s clinical‑stage pipeline includes its lead program, a PD‑1 x VEGF bispecific antibody, as well as novel antibody‑drug conjugates. By leveraging multiple modalities and established targets, Crescent...

Overview:The Corporate Director of Financial Planning & Analysis (FP&A) will lead Revvity's corporate FP&A team, providing strategic financial insights and analysis to drive company-wide financial performance. This key leadership role partners closely with business and finance executives to shape financial strategy while ensuring alignment across investor...

About UsCrescent Biopharma's vision is to build a world leading oncology company bringing the next wave of therapies for cancer patients. The Company's clinical-stage pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates. By leveraging multiple modalities and established targets, Crescent aims to...

Company Overview:Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for myotonic dystrophy type 1 (DM1) and...